AKRO logo

Akero Therapeutics, Inc. (AKRO) Return On Equity

Annual ROE:

-39.22%-4.00%(-11.36%)
December 31, 2024

Summary

  • As of today, AKRO annual return on equity is -39.22%, with the most recent change of -4.00% (-11.36%) on December 31, 2024.
  • During the last 3 years, AKRO annual ROE has risen by +7.89% (+16.75%).
  • AKRO annual ROE is now -11.36% below its all-time high of -35.22%, reached on December 31, 2023.

Performance

AKRO ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKROprofitability metrics

Quarterly ROE:

-32.30%-0.35%(-1.10%)
June 30, 2025

Summary

  • As of today, AKRO quarterly return on equity is -32.30%, with the most recent change of -0.35% (-1.10%) on June 30, 2025.
  • Over the past year, AKRO quarterly ROE has dropped by -2.09% (-6.92%).
  • AKRO quarterly ROE is now -17.50% below its all-time high of -27.49%, reached on September 30, 2023.

Performance

AKRO Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKROprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

AKRO ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-11.4%-6.9%
3Y3 Years+16.8%+48.3%
5Y5 Years+8.8%+28.9%

AKRO ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-11.4%+16.8%-17.5%+46.5%
5Y5-Year-11.4%+16.8%-17.5%+48.3%
All-TimeAll-Time-11.4%+96.3%-17.5%+99.3%

AKRO ROE History

DateAnnualQuarterly
Jun 2025
-
-32.30%(-1.1%)
Mar 2025
-
-31.95%(+7.0%)
Dec 2024
-39.22%(-11.4%)
-34.36%(-1.4%)
Sep 2024
-
-33.88%(-12.1%)
Jun 2024
-
-30.21%(+2.7%)
Mar 2024
-
-31.04%(+3.2%)
Dec 2023
-35.22%(+22.1%)
-32.05%(-16.6%)
Sep 2023
-
-27.49%(+17.1%)
Jun 2023
-
-33.17%(+24.6%)
Mar 2023
-
-43.98%(+11.0%)
Dec 2022
-45.20%(+4.1%)
-49.39%(+18.1%)
Sep 2022
-
-60.33%(+3.3%)
Jun 2022
-
-62.41%(-9.5%)
Mar 2022
-
-56.97%(-23.5%)
Dec 2021
-47.11%
-46.12%(-13.8%)
Sep 2021
-
-40.52%(+5.0%)
DateAnnualQuarterly
Jun 2021
-
-42.66%(-4.9%)
Mar 2021
-
-40.67%(+8.0%)
Dec 2020
-40.89%(+4.9%)
-44.21%(-6.0%)
Sep 2020
-
-41.71%(+8.1%)
Jun 2020
-
-45.41%(-11.7%)
Mar 2020
-
-40.65%(-6.8%)
Dec 2019
-43.00%(+80.2%)
-38.05%(+52.6%)
Sep 2019
-
-80.33%(+4.8%)
Jun 2019
-
-84.41%(+29.6%)
Mar 2019
-
-119.96%(-9.8%)
Dec 2018
-217.19%(+79.3%)
-109.23%(+97.7%)
Sep 2018
-
-4767.66%(-115.7%)
Jun 2018
-
-2210.78%(-897.8%)
Mar 2018
-
-221.56%(-77.2%)
Dec 2017
-1046.79%
-
Dec 2017
-
-125.00%

FAQ

  • What is Akero Therapeutics, Inc. annual return on equity?
  • What is the all-time high annual ROE for Akero Therapeutics, Inc.?
  • What is Akero Therapeutics, Inc. annual ROE year-on-year change?
  • What is Akero Therapeutics, Inc. quarterly return on equity?
  • What is the all-time high quarterly ROE for Akero Therapeutics, Inc.?
  • What is Akero Therapeutics, Inc. quarterly ROE year-on-year change?

What is Akero Therapeutics, Inc. annual return on equity?

The current annual ROE of AKRO is -39.22%

What is the all-time high annual ROE for Akero Therapeutics, Inc.?

Akero Therapeutics, Inc. all-time high annual return on equity is -35.22%

What is Akero Therapeutics, Inc. annual ROE year-on-year change?

Over the past year, AKRO annual return on equity has changed by -4.00% (-11.36%)

What is Akero Therapeutics, Inc. quarterly return on equity?

The current quarterly ROE of AKRO is -32.30%

What is the all-time high quarterly ROE for Akero Therapeutics, Inc.?

Akero Therapeutics, Inc. all-time high quarterly return on equity is -27.49%

What is Akero Therapeutics, Inc. quarterly ROE year-on-year change?

Over the past year, AKRO quarterly return on equity has changed by -2.09% (-6.92%)
On this page